Shenzhen GuoHua Network Security Technology Co., Ltd. (000004.SZ)

CNY 20.63

(10.03%)

Market Cap (In CNY)

2.73 Billion

Revenue (In CNY)

110.04 Million

Net Income (In CNY)

-156.99 Million

Avg. Volume

20.3 Million

Currency
CNY
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
8.32-24.81
PE
-15.03
EPS
-1.19
Beta Value
0.391
ISIN
CNE0000000Y2
CUSIP
-
CIK
-
Shares
132380000.0
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Biotechnology
CEO
Mr. Xiang Huang
Employee Count
-
Website
https://www.sz000004.cn
Ipo Date
1991-01-02
Details
Shenzhen GuoHua Network Security Technology Co., Ltd., together with its subsidiaries, researches, develops, manufactures, and sells bio-pharmaceutical products in China. It offers products in the areas of cardiovascular, anti-infective, tumor immunity, nerve/analgesic, API, and gastrointestinal/reproductive. The company also provides clindamycin phosphate, adenosine triphosphate magnesium chloride, diisopropylamine dichloroacetate, cyclophosphamide, cytidine triphosphate disodium, urokinase, and other injection products. In addition, it engages in the development and sale of real estate properties, as well as housing property management activities. The company was formerly known as Shenzhen Cau Technology Co., Ltd and changed its name to Shenzhen GuoHua Network Security Technology Co., Ltd. in November 2020. Shenzhen GuoHua Network Security Technology Co., Ltd., was founded in 1990 and is based in Shenzhen, China.